(Q44623901)

4 December 2017

title

Synergy between publication and promotion: comparing adoption of new evidence in Canada and the United States (English)

1 reference

4 December 2017

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14567371

23 March 2024

3

Stephen B Soumerai

1 reference

4 December 2017

2

Finlay A. McAlister

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14567371

23 March 2024

author name string

Sumit R. Majumdar

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14567371

23 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

4 December 2017

15 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14567371

full work available at URL

23 March 2024

https://api.elsevier.com/content/article/PII:S0002934303004224?httpAccept=text/xml

1 reference

10.1016/S0002-9343(03)00422-4

DOI

https://api.crossref.org/works/10.1016/S0002-9343(03)00422-4

https://api.elsevier.com/content/article/PII:S0002934303004224?httpAccept=text/plain

23 March 2024

1 reference

10.1016/S0002-9343(03)00422-4

DOI

https://api.crossref.org/works/10.1016/S0002-9343(03)00422-4

American Journal of Medicine

23 March 2024

published in

1 reference

4 December 2017

volume

115

1 reference

4 December 2017

issue

6

1 reference

4 December 2017

page(s)

467-472

1 reference

Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

The impact of clinical trials on the use of medications for acute myocardial infarction. Results of a community-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

Relation between prepublication release of clinical trial results and the practice of carotid endarterectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

Scientific versus commercial sources of influence on the prescribing behavior of physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

Trends in antihypertensive drug advertising, 1985-1996.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

ACE inhibition in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

Therapeutic-class wars--drug promotion in a competitive marketplace

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

Aldosterone and spironolactone in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

Users' Guides to the Medical Literature: XIX. Applying clinical trial results B. Guidelines for determining whether a drug is exerting (more than) a class effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

Putting evidence into practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

Do the investigative sites that take part in a positive clinical trial translate that evidence into practice?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

Influence of a randomized clinical trial on practice by participating investigators: lessons from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). CAVEAT I and II Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

Revisiting the Canadian health care system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

A tale of two countries: Insights from the differences in Canadian/American patterns of care for patients with acute coronary syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900422-4

10.1016/S0002-9343(03)00422-4

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference